Latent S49P neuroserpin forms polymers in the dementia familial encephalopathy with neuroserpin inclusion bodies

被引:44
作者
Onda, M
Belorgey, D
Sharp, LK
Lomas, DA
机构
[1] Univ Cambridge, Cambridge Inst Med Res, Dept Med, Cambridge CB2 2XY, England
[2] Osaka Womens Univ, Fac Sci, Dept Environm Sci, Sakai, Osaka 5900035, Japan
关键词
D O I
10.1074/jbc.M413282200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The serpinopathies result from conformational transitions in members of the serine proteinase inhibitor superfamily with aberrant tissue deposition or loss of function. They are typified by mutants of neuroserpin that are retained within the endoplasmic reticulum of neurons as ordered polymers in association with dementia. We show here that the S49P mutant of neuroserpin that causes the dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) forms a latent species in vitro and in vivo in addition to the formation of polymers. Latent neuroserpin is thermostable and inactive as a proteinase inhibitor, but activity can be restored by refolding. Strikingly, latent S49P neuroserpin is unlike any other latent serine proteinase inhibitor (serpin) in that it spontaneously forms polymers under physiological conditions. These data provide an alternative method for the inactivation of mutant neuroserpin as a proteinase inhibitor in FENIB and demonstrate a second pathway for the formation of intracellular polymers in association with disease.
引用
收藏
页码:13735 / 13741
页数:7
相关论文
共 48 条
[31]   The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes [J].
Makarova, A ;
Mikhailenko, I ;
Bugge, TH ;
List, K ;
Lawrence, DA ;
Strickland, DK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50250-50258
[32]   VARIABLE SELECTION METHOD IMPROVES THE PREDICTION OF PROTEIN SECONDARY STRUCTURE FROM CIRCULAR-DICHROISM SPECTRA [J].
MANAVALAN, P ;
JOHNSON, WC .
ANALYTICAL BIOCHEMISTRY, 1987, 167 (01) :76-85
[33]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) IS A SPONTANEOUSLY POLYMERIZING SERPIN - BIOCHEMICAL-CHARACTERIZATION OF THE RECOMBINANT INTRACELLULAR AND EXTRACELLULAR FORMS [J].
MIKUS, P ;
URANO, T ;
LILJESTROM, P ;
NY, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 218 (03) :1071-1082
[34]   Mutants of neuroserpin that cause dementia accumulate as polymers within the endoplasmic reticulum [J].
Miranda, E ;
Römisch, K ;
Lomas, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (27) :28283-28291
[35]   STRUCTURAL BASIS OF LATENCY IN PLASMINOGEN-ACTIVATOR INHIBITOR-1 [J].
MOTTONEN, J ;
STRAND, A ;
SYMERSKY, J ;
SWEET, RM ;
DANLEY, DE ;
GEOGHEGAN, KF ;
GERARD, RD ;
GOLDSMITH, EJ .
NATURE, 1992, 355 (6357) :270-273
[36]   The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin [J].
Osterwalder, T ;
Cinelli, P ;
Baici, A ;
Pennella, A ;
Krueger, SR ;
Schrimpf, SP ;
Meins, M ;
Sonderegger, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (04) :2312-2321
[37]   Neuroserpin, an axonally secreted serine protease inhibitor [J].
Osterwalder, T ;
Contartese, J ;
Stoeckli, ET ;
Kuhn, TB ;
Sonderegger, P .
EMBO JOURNAL, 1996, 15 (12) :2944-2953
[38]   Neuroserpin regulates neurite outgrowth in nerve growth factor-treated PC12 cells [J].
Parmar, PK ;
Coates, LC ;
Pearson, JF ;
Hill, RM ;
Birch, NP .
JOURNAL OF NEUROCHEMISTRY, 2002, 82 (06) :1406-1415
[39]   Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA [J].
Renatus, M ;
Engh, RA ;
Stubbs, MT ;
Huber, R ;
Fischer, S ;
Kohnert, U ;
Bode, W .
EMBO JOURNAL, 1997, 16 (16) :4797-4805
[40]   MUTATIONS WHICH IMPEDE LOOP SHEET POLYMERIZATION ENHANCE THE SECRETION OF HUMAN ALPHA(1)-ANTITRYPSIN DEFICIENCY VARIANTS [J].
SIDHAR, SK ;
LOMAS, DA ;
CARRELL, RW ;
FOREMAN, RC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (15) :8393-8396